People with bipolar disorder often struggle with mood swings that disrupt their lives. A new analysis looked at a chemical called glial cell line-derived neurotrophic factor, or GDNF, to see if it could help explain these struggles. GDNF is a protein that supports brain cells. Researchers combined data from many studies to get a clearer picture. They found that people with bipolar disorder had significantly lower levels of this chemical compared to healthy people. The difference was large and consistent across the groups studied. This suggests a biological change in the brain that goes along with the illness. However, the studies looked at different groups of patients and used different methods. This mix made it hard to draw firm conclusions. The results also showed that taking treatment did not change these chemical levels in a meaningful way. This means the low levels are likely part of the illness itself rather than a reaction to medication. While this finding is interesting, it is not enough to use the chemical as a test for the disease. More research is needed to understand exactly what this chemical does in the brain.
Brain chemical levels differ in bipolar disorder compared to healthy people
Photo by Navy Medicine / Unsplash
What this means for you:
Lower levels of a brain chemical were found in people with bipolar disorder compared to healthy people. More on Schizophrenia
Blood biomarker variance in UK Biobank influenced by technical, demographic, and behavioral factors Why Blood Tests Fail to Predict Mental Health
medRxiv · Apr 22, 2026
GLP-1RAs reduce weight and HbA1c in severe mental illness with low discontinuation rates New drugs help people with severe mental illness lose weight safely
· May 1, 2026
Meta-analysis reviews psychosis prevalence in bipolar disorder patients across 285 studies Psychosis common in bipolar disorder, review finds
· May 1, 2026
Observational study identifies sensory perception differences in schizophrenia and first-episode psychosis Simple tests reveal unique sensory signs for early psychosis types
medRxiv · Apr 28, 2026